Citrasate Dry Acid Concentrate and GranuFlo Dry Acid Concentrate are each intended to be used as ...
FDA Device Recall #Z-2084-2021 — Class II — April 28, 2021
Recall Summary
| Recall Number | Z-2084-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 28, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Fresenius Medical Care Holdings, Inc. |
| Location | Waltham, MA |
| Product Type | Devices |
| Quantity | (1) 40 cases (2) 3 cases (3) 4 cases |
Product Description
Citrasate Dry Acid Concentrate and GranuFlo Dry Acid Concentrate are each intended to be used as one component in the preparation of dialysate in a 3-stream proportioning hemodialysis machine according to a physician s prescription. Both concentrates are formulated for use in 45X proportioning systems which proportion a nominal ratio of 1 : 1.72 : 42.28 (acid : bicarbonate : water) to generate dialysate. The dialysate is intended to be pumped through a dialyzer, creating an osmotic gradient across the dialyzer membrane to exchange solutes with blood during hemodialysis.
Reason for Recall
Exposed to freezing temperatures due to refrigerated truck malfunctions
Distribution Pattern
US Distribution to: TX only
Lot / Code Information
Lot Number/UDI: (1) 21ATGF013 (01)00884086110135 0FD3251-3B (2) 20SXGF010 (01)00840861101597 0FD3251-3B (3) 20SXGF013 (01)00840861101597
Other Recalls from Fresenius Medical Care Holdings, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0936-2026 | Class II | 5008X CAREsystem +CLiC +CDX; | Oct 25, 2025 |
| Z-0041-2026 | Class II | Optiflux¿ High Flux E-beam Dialyzer Model Numb... | Aug 29, 2025 |
| Z-1992-2025 | Class II | 5008X HDF Hemodialysis Blood Tubing Set, 24 uni... | Apr 29, 2025 |
| Z-0801-2025 | Class II | Dialyzer Optiflux 160NRe | Dec 5, 2024 |
| Z-3124-2024 | Class II | Blood Pressure Module BPM3 TM-2917B (Spare Part... | Aug 8, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.